The American Thoracic Society's International Conference (ATS) – one of the largest gatherings of pulmonary, critical care, and sleep medicine professionals in the world – held its 113th ATS-Conference in Washington, D.C., 19th-24th May 2017.
International congresses enable clinicians to keep up with advances in research and can be a great source of information for healthcare professionals. That said, the magnitude of data presented and discussed can be overwhelming and not everyone has the opportunity to visit those congresses.
The following online resources are useful for HCPs interested in idiopathic pulmonary fibrosis (IPF) research and clinical practice. For resources for patients and others affected by IPF, please visit our resources for patients page.
The first clinical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis (IPF)1 were published in 2011. In July 2015, the treatment recommendations were updated according to evidence reported since the publication of the prior guidelines.2
The American Thoracic Society's International Conference (ATS) – one of the largest gatherings of pulmonary, critical care, and sleep medicine professionals in the world – was held May 13th-18th in San Francisco, California.
The European Respiratory Society (ERS) – one of the leading international organisations in the respiratory field – brought together specialists working in respiratory medicine at its annual international congress in London, United Kingdom (September 3rd - 7th 2016).
The key to diagnosing idiopathic pulmonary fibrosis (IPF) is a high-resolution computed-tomography (HRCT) scan. If the HRCT scan shows a usual interstitial pneumonia (UIP) pattern and alternative causes of interstitial lung disease (ILD) can be ruled out, a diagnosis of IPF is indicated.
Interstitial lung diseases (ILDs) are referred to as a heterogeneous entity of over 150 lung diseases that have in common to affect the connective tissue giving shape and supportive structure to the lungs (“interstitium”). This interstitium encompasses the alveolar epithelium as well as the interstitial capillaries and the surrounding soft tissue. Many diseases in the group of ILDs are connected to the development of pulmonary fibrosis, which might evolve also at a very late stage.1
The European Respiratory Society (ERS) is one of the leading medical organisations in the respiratory field centering on research, education and advocacy. The International ERS Congress is one of the most significant gatherings in respiratory healthcare with international leaders in the field presenting the latest scientific developments.